Medtronic is Making the Most of Value-Based Care
Medical device companies of all sizes have embraced value-based healthcare in recent years, and one of the industry’s top companies is now beginning to see its value-based care programs pay off.
Laser Direct Structuring for Sensor Manufacturing
Every day the world’s leading medical device companies rely upon laser direct structuring (LDS) to meet their most demanding design and performance requirements. Millions of electronic components with complex geometries are cost-effectively manufactured each year through the use of LDS to create circuit traces on three-dimensional molded interconnect devices (3D-MID).
LivaNova Pumps Up its Heart Portfolio with TandemLife Deal
LivaNova said it will pay up to $250 million for TandemLife, a deal that will significantly bolster its cardiac surgery portfolio.
Medtech Must Move Beyond the Device to Bring More Value to Health Systems
As value-based care becomes more prevalent in the U.S. healthcare model, health systems are focused more than ever on achieving better outcomes, efficiencies, and patient experience.
Read More
Abbott Expands Portfolio of MRI-Ready Devices
FDA gave MR-conditional labeling to two of Abbott’s cardiac rhythm management (CRM) devices, a move that further boosts the company’s ability to compete with its peers in the space.
Why Thailand is an Untapped Medtech Opportunity
Medical tourism, an aging population, and a growing middle-income class are driving rapid growth in Thailand’s medical device market.
Wearable Artificial Kidney Could be Game Changer
The Kidney Research Institute of the University of Washington is developing a wearable artificial kidney that could reach clinical trials by 2022.
New EU MDR Regulations and Revamp of the Medical Device Directive
An overview of the key impact points and challenges of European Union Medical Device Regulation.
Act Now to Prepare for MDSAP Audits
The clock is ticking for medical device manufacturers worldwide. Manufacturers that want to continue selling products in Canada’s $6.7 billion medical device market should be preparing and planning for the international Medical Device Single Audit Program (MDSAP) by now. Canada is the first market to require the MDSAP audit as part of its medical device licensing scheme, beginning Jan. 1, 2019. On that date, companies selling Class II, III, and IV medical devices and IVDs must have an MDSAP Certificate on file with Health Canada to maintain their Canadian Device Licenses.
What Does Amazon’s Healthcare Move Mean for Medtech?
Amazon, Berkshire Hathaway, and JPMorgan Chase caused quite the stir Tuesday with news of a new venture aimed at providing their U.S. employees with “simplified, high-quality, and transparent healthcare at a reasonable cost.” But what does this actually mean for the medical device and diagnostic industry?
